DCLK1-Short Splice Variant Promotes Esophageal Squamous Cell Carcinoma Progression via the MAPK/ERK/MMP2 Pathway.

Abstract

Cancer stem cell (CSC) marker doublecortin-like kinase 1 (DCLK1) contributes greatly to the malignancy of gastrointestinal cancers, and DCLK1-targeted agents have potential therapeutic value. However, the molecular pathways regulated by DCLK1-S (DCLK1 isoform 4), a shortened splice variant of DCLK1, still remain obscure. Here we found that the expression of DCLK1-S is significantly increased in human esophageal squamous cell carcinoma (ESCC) tissues and associated with malignant progression and poor prognosis. Functional studies indicated that silencing total of DCLK1 mediated by CRISPR/Cas9 inhibited ESCC cell proliferation, migration, and invasion. Conversely, these changes were largely reversed after DCLK1-S rescue or overexpression. More importantly, DCLK1-S significantly enhanced primary tumor formation and metastatic lung colonization in vivo. The Cancer Genome Atlas database and molecular analysis showed that DCLK1-S was closely related to the epithelial-mesenchymal transition (EMT) process in patients with ESCC. Further RNA sequencing and Kyoto Encyclopedia of Genes and Genomes analysis demonstrated that MAPK signaling pathway was significantly enriched. Our in vitro study proclaimed that DCLK1-S induced MMP2 expression in ESCC cells via MAPK/ERK signaling, leading to the activation of EMT. In addition, administration of ERK1/2 blocker SCH772984 attenuated the proliferative and migratory phenotype induced by DCLK1-S. In conclusion, these findings suggest that DCLK1-S may be a key molecule in MAPK/ERK/MMP2 pathway-mediated progression of ESCC, and that it has potential as a biomarker or therapeutic target to improve outcomes in patients with ESCC. IMPLICATIONS: : DCLK1-S induces ESCC progression by activating the MAPK/ERK/MMP2 axis and may serve as a prognostic biomarker or therapeutic target for patients with ESCC.

• Authors: Yang Ge, Xiaona Fan, Xuying Huang, Nathaniel Weygant, Zeru Xiao, Rui Yan, Heshu Liu, Jian Liu, Guangyu An, Jiannan Yao
• Journal: Molecular cancer research : MCR (Mol Cancer Res) Vol. 19 Issue 12 Pg. 1980-1991 (12 2021) ISSN: 1557-3125 [Electronic] United States
• PMID: 34610960 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: ©2021 American Association for Cancer Research.

Chemical References

• DCLK1 protein, human
• Doublecortin-Like Kinases

Topics

• Animals
• Cell Line, Tumor
• Cell Proliferation
• Disease Progression
• Doublecortin-Like Kinases (metabolism)
• Esophageal Neoplasms (genetics, mortality, pathology)
• Esophageal Squamous Cell Carcinoma (genetics, mortality, pathology)
• Female
• Humans
• MAP Kinase Signaling System (genetics)
• Mice
• Mice, Nude
• Middle Aged
• Survival Analysis